✦ LIBER ✦

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

✍ Scribed by Ricardo Bellott; Anne Auvrignon; Thierry Leblanc; Yves Pérel; Virginie Gandemer; Yves Bertrand; Françoise Méchinaud; Patrice Bellenger; Jérôme Vernois; Guy Leverger; André Baruchel; Jacques Robert

Publisher: Springer
Year: 2000
Tongue: English
Weight: 118 KB
Volume: 47
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s002800000206

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction toxicity of a modified Memoria

Induction toxicity of a modified Memorial Sloan-Kettering-New York II protocol in children with relapsed acute lymphoblastic leukemia: A single institution study

✍ Morland, Bruce J.; Shaw, Peter J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Although the chance of cure for children with acute lymphoblastic leukaemia (ALL) is high, their outlook with subsequent relapse is poor. Bone marrow transplantation may be an option for some, but the need for intensive reinduction chemotherapy regimens remains the best hope for effecting cure in th

A phase I study of carboplatin in childr

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse: A report from the childrens cancer group

✍ Lawrence J. Ettinger; Mark D. Krailo; Paul S. Gaynon; G. Denman Hammond 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

High-dose cytosine arabinoside and dauno

High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the southeastern cancer study group

✍ Hillard M. Lazarus; W. Ralph Vogler; C. Patrick Burns; Elliott F. Winton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 571 KB